Ameriprise
IMI

Ameriprise’s Intermolecular, Inc. IMI Stock Holding History

Ameriprise’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,000
Closed -$49K – 5445
2013
Q4 		$49K Sell
10,000
-1,075
-10% -$6.07K ﹤0.01% 3671
2013
Q3 		$61K Hold
11,075
– – ﹤0.01% 3718
2013
Q2 		$81K Buy
+11,075
New +$94.3K ﹤0.01% 3466

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise's IMI Position: Q1 2014 in Review

Ameriprise sold out of Intermolecular, Inc. (IMI) in Q1 2014, closing a stake of 10,000 shares — an estimated $49K sold.

Ameriprise first reported a position in IMI in Q2 2013 and held it in 3 quarters. The position peaked at $81K in Q2 2013. 53 funds tracked by Wall St. Rank hold IMI as of Q1 2014.

  • Ameriprise reported no remaining Intermolecular, Inc. position as of Q1 2014 after selling out during the quarter.
  • Ameriprise sold 10,000 Intermolecular, Inc. shares in Q1 2014, an estimated $49K.
  • Ameriprise first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 3 quarters.
  • Ameriprise's Intermolecular, Inc. position peaked at $81K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2014.

Based on Ameriprise's 13F filing for Q1 2014, filed 14 May 2014.